.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Army
Fuji
Novartis
Julphar
AstraZeneca
Argus Health
Healthtrust
QuintilesIMS
Johnson and Johnson

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202334

« Back to Dashboard
NDA 202334 describes LEVONORGESTREL, which is a drug marketed by Novel Labs Inc, Wyeth Pharms Inc, Lupin Ltd, Perrigo R And D, Mylan Labs Ltd, Glenmark Pharms Ltd, Reckitt Benckiser, Watson Labs, Watson Labs Inc, Oc Pharma, Lotus Pharm Co Ltd, Mayne Pharma, Amneal Pharms, Barr, and Glenmark Generics, and is included in thirty-seven NDAs. It is available from sixteen suppliers. Additional details are available on the LEVONORGESTREL profile page.

The generic ingredient in LEVONORGESTREL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Summary for 202334

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202334

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVONORGESTREL
levonorgestrel
TABLET;ORAL 202334 ANDA L. Perrigo Company 0113-2003 0113-2003-12 1 BLISTER PACK in 1 CARTON (0113-2003-12) > 1 TABLET in 1 BLISTER PACK
LEVONORGESTREL
levonorgestrel
TABLET;ORAL 202334 ANDA Rapha Pharmaceuticals, Inc. 69953-514 69953-514-01 1 BLISTER PACK in 1 CARTON (69953-514-01) > 1 mg in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Aug 20, 2014TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chubb
Healthtrust
UBS
US Army
McKinsey
Harvard Business School
Boehringer Ingelheim
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot